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CURRENT INTERNATIONAL TRENDS
IN SEVERE ACUTE BRAIN TRAUMA
JULIO CRUZ*
ABSTRACT - A comprehensive review is presented on current international trends regarding research and
management of severe acute brain trauma. Controversial issues are thoroughly discussed and an attempt is made
to clarify questionable aspects from pertinent publications in the international literature. A proposition is made to
manage not only intracranial pressure and perfusion pressure, but also cerebral hemometabolic parameters in
these critically ill patients. Currently available management guidelines are not evidence-based.
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Tendências internacionais atuais em traumatismo cerebral agudo grave
RESUMO - Uma revisão abrangente é apresentada referente a tendências internacionais atuais em pesquisa e
tratamento do traumatismo cerebral agudo grave. Aspectos controversos são discutidos, e é feita tentativa de
esclarecer pontos questionáveis da literatura internacional pertinente. Uma proposicão e feita para que sejam
tratados nao somente a pressão intracraniana e a pressão de perfusão cerebral, mas também parâmetros
hemometabólicos cerebrais nestes pacientes gravemente enfermos. Normas (“guidelines”) atualmente disponíveis
para tratamento não são baseadas em evidência.
PALAVRAS-CHAVE: traumatismo cerebral, pressão intracraniana, pressão de perfusão cerebral, extração
cerebral de oxigênio.
Over the past decade, conflicting information has been addressed with regard to research and
management of severe acute brain trauma, so that heterogeneous standards for acute patient care
have become apparent. With the exception of life-saving measures at the prehospital and emergency
room levels, which are believed standardized in most developed and developing countries, diverse
strategies have been reported in the intensive care unit setting.
This review is aimed at discussing and clarifying findings that have been reported in the
pertinent international literature, as an attempt to guide neuroprofessionals toward better understanding
clinical research and management propositions, insofar as neuro critical care is concerned.
Intracranial pressure and cerebral hemometabolism
In addition to the presence of acute intracranial lesions with mass effect (most of them promptly
managed surgically), intracranial pressure (ICP) problems during intensive care have been frequently
attributed to the presence of brain edema and subarachnoid hemorrhage. Despite ongoing research
over the years, however, little is known about the influence of changes in cerebral blood volume
(CBV). Nevertheless, cerebral blood flow (CBF) is directly proportional to CBV, and several studies
have addressed variable CBF patterns during the acute phase of injury.
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Perhaps the most informative paper from the 1980s1 addressed a statistically significant
association between cerebral hyperemia and intracranial hypertension, in contrast with predominantly
reduced CBF during periods of normal ICP. In this latter report1, hyperemia was also described as
normal CBF levels (in absolute values), which were nevertheless associated with decreased global
cerebral oxygen extraction, as measured by the arteriojugular oxygen content difference (AVDO2);
that is, the finding of relative cerebral hyperperfusion with normal CBF was clear because cerebral
oxygen consumption was pathologically reduced, and not only high but also normal CBF levels
were associated with low oxygen extraction. From our findings1, global cerebral ischemia was
essentially ruled out in severe acute brain trauma.
In contrast, the Richmond group2 later addressed a 33% rate of early global brain ischemia in
35 patients with severe acute brain trauma, during the first 6 hours after injury. However, despite
CBF values in the low range, AVDO2 did not exceed the upper normal limit of 8.3 vol%3 in any of
the studied patients (Figure 1 of Bouma’s paper2). Therefore, the true rate of “pre-ischemic” or
“potentially ischemic” levels of cerebral oxygen extraction was zero percent. In contrast, starting at
approximately 12 postinjury hours, relative cerebral hyperperfusion represented a general rule
throughout the acute phase, as determined by AVDO2 values below the lower normal limit of 5.1
vol%3 (Table 1 of that paper2). Unlike our previous report1, in the Richmond series2 no emphasis was
placed on ICP problems relative to CBF and AVDO2.
We4 later reported that AVDO2 is an unreliable parameter of cerebral oxygen extraction in
either moderate or profound acute anemia, and proposed a new variable termed cerebral extraction
of oxygen (CEO2, the arteriojugular oxyhemoglobin saturation difference4-8). Moderate acute anemia
is frequent during intensive care and is not managed under several circumstances. AVDO2
underestimates cerebral oxygen extraction while CEO2 does not. Therefore, AVDO2 overestimates
cerebral hyperemia (unlike CEO2)4. Accordingly, therapeutic modalities for elevated ICP based on
cerebral vasoconstriction (hyperventilation, dihydroergotamine, indomethacin, barbiturates,
hypothermia, etc) can be optimized based on CEO2 more accurately than by AVDO2. The same
applies to therapies that simultaneously lower the ICP and increase cerebral venous oxygenation
and CBF, such as mannitol6.
Cerebral perfusion pressure
First proposed by Langfitt et al.9, cerebral perfusion pressure (CPP, the difference between
mean arterial pressure and mean ICP) has been “re-visited” by Rosner et al.10. These latter authors
have proposed managing acute brain trauma with the head flat, normocapnic throughout the acute
phase, with induced arterial hypertension as a means of maintaining CPP above 70 mm Hg. Except
for mannitol and cerebrospinal fluid drainage, none of the above-mentioned therapies was adopted
in Rosner’s experience10.
As described above, however, relative cerebral hyperperfusion (rather than ischemia) represents
a general rule during most of the acute postinjury phase and, therefore, cerebral vasoconstrictive
therapies are indicated, in addition to mannitol. Rosner’s claim of improved clinical outcome10 was
not valid because a control group was not evaluated. Rather, Rosner et al.10 calculated chi-square
outcome statistics using their patient population against that of the American Traumatic Coma Data
Bank. The two populations were not comparable, however, because in Rosner’s series only 35% of
the patients had brain swelling, with a low 16% rate of compromised basilar cisterns, indicative of a
less severe patient population than that of the coma bank.
A recent report11 involving over 400 patients has made it clear that CPP levels above 60 mm
Hg are not associated with improved clinical outcome, and that intracranial hypertension (rather
than CPP) is the most devastating phenomenon in association with poor outcome figures. Furthermore,
Rosner’s patients underwent an average 18-day of ICP and CPP monitoring (with a 29% mortality
rate)10, versus one week only (with a low 9% mortality rate) in our large series12 of over 350
prospectively evaluated, selected patients with high ICP and brain swelling, in whom therapeutic
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measures were adopted to normalize not only ICP and CPP, but also CEO2. Therefore, Rosner’s
proposal10 induces intracranial hypertension, with resulting ultra-prolonged monitoring and high
mortality rate relative to the presence of acutely decreased cerebrospinal fluid spaces.
From the above discussion, “CPP management” totally ignores the natural history of cerebral
hemodynamics and metabolism in severe acute brain trauma; that is, a state of initially reduced CBF
normally coupled with reduced cerebral oxygen consumption, which is then followed by a prolonged,
sustained pattern of relative cerebral hyperperfusion. Furthermore, we13 have also unequivocally
demonstrated that normal-to-increased CPP holds absolutely no correlation with cerebral oxygen
metabolism (both oxygen extraction and consumption), thus ruling out any beneficial effect of normal-
to-increased CPP levels13. Accordingly, “CPP management” as previously proposed10 involves more
deleterious than beneficial effects both on intracranial dynamics and clinical outcome.
Combined cerebral oxygen and glucose metabolism
Back in 1995, we8 reported a state of global cerebral hypoglycolysis during near normocapnia
(when ICP problems had subsided); that is, cerebral extraction of glucose was pathologically reduced
relative to CEO2, a condition that markedly improved during optimized hyperventilation (which
simultaneously normalized ICP, CEO2 and cerebral extraction of glucose)8.
In a later report, however, Bergsneider et al.14 addressed cerebral hyperglycolysis also during
near normocapnia. This “hypermetabolic” condition, however, was a function of a methodological
artifact, because the ratio of cerebral glucose to oxygen consumption was calculated using cortical
glucose values against global oxygen measurements. Yet, it is well known that global metabolic
values are far lower than cortical ones.
Cerebral blood flow alone
In the normal (awake) monkey brain15, ischemic CBF thresholds have been addressed at
levels below 18 mL/100g/min. In comatose patients, however, cerebral oxygen consumption
frequently falls by approximately 50% (or more) 16. Accordingly, ischemic CBF thresholds in comatose
patients are expectedly 50% lower than in the normal brain, or 9 mL/100g/min17. Therefore, research
involving regional or global CBF alone in comatose patients has emphatically overemphasized
cerebral ischemia without the necessary concomitant metabolic data 18-21. In this respect, regional
CBF values as high as 40 mL/100g/min have been proposed as “ischemic” in acute coma21, an
approach that appears to be conceptually inadequate.
Optimized versus indiscriminate hyperventilation
Optimized hyperventilation has been proposed in our work7,8,12 as a means of not only
normalizing ICP but also CEO2. By doing so, we have introduced intentional restoration of the
clinically beneficial coupling between CBF and oxygen consumption. In this respect, a previous
study by Jaggi et al.16 addressing observational (non interventional) research has disclosed better
clinical outcome of patients when global cerebral oxygen extraction is spontaneously found within
the normal range than when relative cerebral hyperperfusion (decreased oxygen extraction) exists
during the acute postinjury phase.
In a recent prospective, controlled trial involving a large number of patients, we12 have
addressed statistically better clinical outcome figures in patients subjected to both moderate and
profound optimized hyperventilation (based on CEO2 monitoring), than in the control group where
only mild non optimized hyperventilation was adopted (because CEO2 monitoring was not adopted).
In contrast to the above findings, Muizelaar et al.22 have addressed adverse effects of
hyperventilation, but in a small group of patients randomly assigned to hypocapnic treatment. In this
latter report, however, only 14% of the patients had elevated ICP when hyperventilation was initially
instituted (Table 1 of that paper22). Accordingly, hyperventilation was contraindicated in as many as
86% of the randomized patients; that is, hyperventilation was used indiscriminately. These “adverse
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effects” were described as a “slowness” in neurologic recovery which, nevertheless, was no different
from the control group at one year postinjury.
Because of the small number of patients in those randomized groups22, only 5-6 patients with
more severe lesion types (e.g., diffuse axonal injury) could have well explained the observed
“slowness” in neurologic recovery (typical of axonal injury), rather than an adverse effect of
hyperventilation itself. Moreover, the mortality rate was 18% higher in non hyperventilated patients,
which corresponds to approximately half the mortality rate reported by others1,10,23; that is, Muizelaar
et al.22 did not hyperventilate patients at random even in the presence of elevated ICP and progressing
signs of tentorial herniation (in order not to violate the randomization scheme) when, in fact, half of
those who died could have been saved if hyperventilated.
As previously reported7,8, optimized hyperventilation presents with the very largest number
of positive physiologic effects in comparison with any other treatment modality for acute brain
injury with intracranial hypertension. These positive effects are as follows: 1) prompt normalization
of elevated ICP7; 2) normalization of decreased CEO2 (or relative hyperperfusion), thereby restoring
normal coupling between CBF and oxygen consumption7; 3) normalization of pathologically
decreased cerebral extraction of glucose8; 4) restoration of normal coupling between cerebral oxygen
and glucose extraction, thereby restoring normal cerebral aerobic metabolism8; 5) normalization of
CPP without the need for vasopressor drugs7,8; and 6) improvement or maintenance of adequate
systemic hemodynamics and oxygenation7. These multiple positive physiologic effects explain the
recently reported findings of improved clinical outcome in optimally hyperventilated patients in
comparison with a control group12.
Optimized mannitol
Also based on CEO2 monitoring, optimization of mannitol administration has become possible6.
In this latter report, we described a simultaneous decrease in elevated ICP and normalization of
increased CEO2 (or cerebral oligemia). Accordingly, in light of these findings, mannitol cannot be
optimized based on ICP measurements only6; that is, mannitol is not optimally administered when
high ICP is associated with decreased CEO2 (relative hyperperfusion), because mannitol further
increases CBF. This latter finding may explain a “rebound” effect, when ICP recurrently increases
shortly after mannitol administration.
Optimized barbiturate therapy
Unlike optimized hyperventilation and mannitol6-8,12, barbiturate (pentobarbital) therapy has
been reported in association with transiently decreased cerebral venous oxygenation in some patients
with refractory ICP24. These undesired findings were addressed shortly following the intravenous
bolus injections, when the blood pressure fell. Accordingly, a transient decrease in cerebral
oxygenation to oligemic hypoxic levels may be observed following barbiturate boluses, even though
no adverse effects have been found during prolonged barbiturate maintenance infusion.
Additional therapies
In light of the above-described findings, it is apparent that virtually all therapeutic modalities
for elevated ICP may be optimized by CEO2 monitoring rather than by ICP and CPP only. This is
particularly true because most therapies influence CBF and/or oxygen metabolism. Future studies
will tell us more about that.
Alternative monitoring modalities
Stocchetti, et al.25 have proposed bilateral jugular monitoring, as they found side-to-side
differences of up to 15%. In their experience, however, continuous fiberoptic jugular monitoring
was not carried out with strict immobilization of the patient’s neck, so that much of their described
differences may have been artifactual. This is because the fiberoptic jugular catheter may easily
generate artifactual readings even with minor changes in head positioning. In light of improved
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clinical outcome from a large series of patients subjected to unilateral continuous fiberoptic jugular
monitoring12, it is therefore apparent that bilateral jugular catheterization should not be considered.
Non invasive near infrared spectroscopy for mixed arteriolar and venular monitoring is being
abandoned because, unlike the normal brain26, this technique fails to demonstrate large hypoxic
changes in jugular oxyhemoglobin saturation in injured brains27. This limitation is probably because
the technology assumes normal arteriolo-venular compartmental distribution in injured brain, which
may not be true under several circumstances.
Highly invasive, acutely implanted probes into brain tissue have also been proposed for both
tissue oxygen monitoring and evaluation of other elements by microdialysis28. In this respect, however,
acutely implanted brain tissue probes (even the smallest ones) produce focal microvascular
compression and distortion, besides blood-brain barrier alterations. Therefore, artifactual
abnormalities such as low tissue oxygen and high tissue lactate may be found28, which may have no
relationship with the rest of the brain that is not under mechanical load. Accordingly, it is also likely
that brain tissue probes will soon be abandoned, at least by those who acknowledge their inherent
technical limitations.
From the above discussion, unilateral jugular monitoring still represents the gold standard for
bedside cerebral hemometabolic monitoring and management. For regional evaluation, however,
CBF alone is not adequate, because concomitant metabolic information is always mandatory in
injured brain. In this respect, out of the intensive care unit techniques are therefore required, such as
positron emission tomography and/or functional magnetic resonance imaging. These two latter
diagnostic modalities, however, are not suitable for acutely ill, unstable patients, to whom the intensive
care unit still represents the most protective environment.
GUIDELINES
Back in 1996, guidelines for the management of severe acute brain trauma were reported and
said to be evidence-based29. Those authors claimed that hyperventilation should be avoided and that
normocapnic “CPP management”10 should be adopted. As described above, however, optimized
hyperventilation7,8 was reported before those guidelines were written. Because optimized
hyperventilation provides the largest number of positive physiologic effects in comparison with any
other therapeutic modality7,8, it then becomes clear that those guidelines29 are not evidence-based.
Furthermore, normocapnic “CPP management”10 is contraindicated in patients with acutely
decreased cerebrospinal fluid spaces under most circumstances, as outlined above. As of 1998, combined
management of ICP, CPP and CEO2 by optimized hyperventilation (besides other therapies) has been
clearly reported in association with improved clinical outcome12. It therefore remains for future, alternative
guidelines to fully cover the pertinent literature in an unbiased fashion, so that true evidence-based
information may become available to those involved in neuro critical care medicine.
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